FTLF Earnings

FTLF reported its FY2025Q3 earnings on 2025-11-13, showcasing a revenue of 23.00M against an estimate of 24.00M, resulting in a -1.63% surprise. The EPS was 0.19, surpassing the expected 0.25 by -24% . The stock experienced a -2.01% price change on the earnings day and a -0.46% change over the next five days, reflecting market reactions to the results.

Following FTLF's FY2025Q3 earnings announcement on 2025-11-13, the stock price moved by -2.01% on the day of the release. Over the subsequent five days, it saw a -0.46% change. Historically, FTLF's stock price tends to shift by an average of -2.21% in the 10 days leading up to earnings and +5.63% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate FTLF’s annual revenue to reach 27.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.63% and EPS estimates Revise Downward by -1.89% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between FTLF's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.63%, while EPS estimates moved Revise Downward by -1.89% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FTLF's stock price typically moves by -2.21% in the 10 days before its earnings and +5.63% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 27.00M.

The earnings call reveals several negative factors: declining margins, increased tax expenses, and unresolved issues with Dr. Tobias on Amazon. Although MusclePharm shows growth, it's primarily from existing customers. Rising protein costs and potential further margin declines are concerning. Despite optimistic guidance for Irwin's online sales, the lack of clarity on subscriber trends and management's avoidance of detailed responses contribute to a negative sentiment. Without a market cap, the negative impact is assumed to be moderate.